XML 26 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities      
Net income $ 410,573,000 $ 337,257,000 $ 271,109,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Loss (gain) on sale of fixed assets - net 946,000 315,000 (28,000)
Loss (gain) on sale of businesses - net 0 (9,273,000) 22,298,000
Asset impairments 0 0 205,000
Depreciation and amortization 39,049,000 38,314,000 37,854,000
Amortization of intangible assets 38,495,000 45,902,000 49,038,000
Amortization of debt issuance expenses 1,332,000 1,320,000 1,295,000
Share-based compensation expense 24,754,000 24,405,000 20,326,000
Deferred income taxes (4,345,000) (33,742,000) (17,308,000)
Non-cash interest expense associated with forward starting swaps (6,475,000) (6,655,000) (6,851,000)
Pension settlement 0 0 3,554,000
Changes in (net of the effect from acquisitions and divestitures):      
Receivables (23,419,000) (15,803,000) 302,000
Inventories (23,031,000) 760,000 32,747,000
Other current assets 25,162,000 (20,031,000) (22,006,000)
Trade accounts payable (1,220,000) 12,556,000 73,000
Accrued expenses 4,148,000 19,710,000 (5,470,000)
Other - net (19,574,000) 24,408,000 (923,000)
Net cash flows provided by operating activities 479,345,000 432,753,000 399,917,000
Cash flows from investing activities      
Purchases of property, plant and equipment (56,089,000) (43,858,000) (38,242,000)
Purchase of intellectual property (4,000,000) 0 0
Acquisition of businesses, net of cash acquired (20,205,000) (38,161,000) (510,001,000)
Proceeds from disposal of fixed assets 363,000 6,011,000 49,000
Proceeds from sale of businesses, net of cash sold   21,795,000 39,064,000
Other - net (1,500,000) (533,000) (69,000)
Net cash flows used in investing activities (81,431,000) (54,746,000) (509,199,000)
Cash flows from financing activities      
Borrowings under revolving credit facilities 0 33,000,000 501,529,000
Payments under revolving credit facilities (11,284,000) (200,618,000) (520,125,000)
Debt issuance costs 0 0 (246,000)
Dividends paid (127,478,000) (111,172,000) (102,650,000)
Proceeds from stock option exercises 27,639,000 22,935,000 30,240,000
Purchases of common stock (173,926,000) (29,074,000) (57,272,000)
Shares surrendered for tax withholding (11,555,000) (6,228,000) (4,928,000)
Settlement of foreign exchange contracts 6,593,000 13,736,000 0
Net cash flows provided by (used in) financing activities (290,011,000) (277,421,000) 46,548,000
Effect of exchange rate changes on cash and cash equivalents (17,446,000) 39,400,000 (29,320,000)
Net increase (decrease) in cash 90,457,000 139,986,000 (92,054,000)
Cash and cash equivalents at beginning of year 375,950,000 235,964,000 328,018,000
Cash and cash equivalents at end of year 466,407,000 375,950,000 235,964,000
Cash paid for:      
Interest 36,327,000 36,818,000 37,067,000
Income taxes - net 90,733,000 104,852,000 109,399,000
Significant non-cash activities:      
Contingent consideration for acquisition 3,375,000 0 0
Capital expenditures for construction of new leased facility $ 11,616,000 0 0
3.20% Senior Notes, due June 2023      
Cash flows from financing activities      
Proceeds from issuance of Senior Notes   0 100,000,000
3.37% Senior Notes, due June 2025      
Cash flows from financing activities      
Proceeds from issuance of Senior Notes   $ 0 $ 100,000,000